The Canada Nuclear Medicine Market Size is Expected to Reach USD 1605.23 Million by 2033, Growing at a CAGR of 14.61% from 2023 to 2033. The manufacturing, distribution, and use of radiopharmaceuticals and nuclear imaging technologies are the focus of the Canada Nuclear Medicine Market. These have both therapeutic (like radiotherapy) and diagnostic imaging (like PET and SPECT) applications. The rising need for improved treatments and early, accurate disease diagnosis is responsible for the expansion of Canada's nuclear medicine sector.